Granules

Granules India subsidiary clears USFDA audit

Hyderabad: The drug maker Granules India on Wednesday announced that its US-based subsidiary cleared a pre-approval inspection (PAI) audit by the US drug regulator. “Granules India Limited announced that Granules Pharmaceuticals, Inc.(GPI),…